Project Grant R56HL173809
Award Date
9/15/24
Completion Date
8/31/25
Dollars Obligated
$678K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90089, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $691,326 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Northwestern University to develop a "4D Right-Heart Virtual Catheter (4D VCATH)". This novel technology combines advanced mathematical modeling and 4D flow MRI to provide a comprehensive, non-invasive hemodynamic analysis of the right heart chambers. The project aims to enable streamlined diagnosis, classification, and prognosis...
The National Heart, Lung, and Blood Institute (NHLBI) has awarded a Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Trustees of Columbia University in the City of New York. The $688,291 grant will fund the development and clinical validation of a novel 3D ultrasound technique called Electromechanical Wave Imaging (EWI) for non-invasive, personalized cardiac arrhythmia mapping. Over a 5-year period ending in June 2029, the project aims to demonstrate that...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, awarded a $726,205 Project Grant to the University of Pittsburgh to develop a new super-resolution intravascular ultrasound (SR-IVUS) technology. The goal is to enable effective imaging of the coronary vasa vasorum (VV) network and thin fibrous cap to assess vulnerable atherosclerotic plaque, which is a leading cause of acute coronary syndromes. The project aims to develop a...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $188,125 to the California State University Long Beach Research Foundation to conduct research on the biomechanics and hemodynamics of the human aorta following thoracic endovascular aortic repair (TEVAR) for type-B aortic dissection. The goal is to characterize the long-term impact of extensive TEVAR on aortic remodeling by...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $656,751 to Third Coast Dynamics, Inc. to develop an artificial intelligence-based platform called "TCDFLOW" that can derive 4D hemodynamic data from routine clinical anatomic images. This will address limitations of current 4D flow MRI techniques, which require specialized equipment and expertise, by enabling the...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the Cardiovascular Diseases Research program (CFDA 93.837), provides $117,000 to the University of Colorado-Denver to conduct secondary analysis of 3D echocardiography images of the right ventricle. The goal is to develop computational methods using machine learning to analyze 3D strain parameters that can better detect early signs of right ventricular dysfunction in pulmonary arterial...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $694,385 Project Grant to the Rector & Visitors of the University of Virginia to develop a method for enhancing the delivery of adeno-associated virus (AAV) gene therapy to the heart. The goal is to improve the efficiency and safety of AAV-based gene therapies for treating cardiovascular diseases by utilizing ultrasound-mediated cavitation of microbubbles to...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $666,609 to North Carolina State University to develop and demonstrate the feasibility of lung quantitative ultrasound (LQUS) for assessing the severity of pulmonary edema due to heart failure and idiopathic pulmonary fibrosis. The goal is to create a real-time, non-invasive, point-of-care method to monitor these lung conditions,...
The University of California, Davis received a $400,417 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) to conduct research on cardiac regenerative therapy using gene-edited stem cells. The goal is to improve transplantation outcomes and address the critical role of inflammation-induced cell death that impedes current cardiac stem cell therapies. The research aims to develop new treatments for end-stage heart failure, a...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $770,000 to the University of Utah to develop an innovative nasal transesophageal echocardiography (nasal-TEE) system. The goal is to create a nasal-TEE prototype that can acquire high-quality cardiac imaging without the need for anesthesia, which would reduce cost, improve workflow, expand availability, and enhance safety...